Sigma Planning Corp Organon & Co. Transaction History

Sigma Planning Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	BUY	$23.31 - $28.61 $491,817 - $603,642	21,099 New	21,099 $0
Q2 2022 Aug 11, 2022	BUY	$31.66 - $38.9 $267,368 - $328,510	8,445 New	8,445 $285,000
Q1 2022 Apr 20, 2022	SELL	$30.45 - $39.36 $643,743 - $832,109	-21,141 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$28.67 - $37.13 $606,112 - $784,965	21,141 New	21,141 $644,000
Q3 2021 Oct 28, 2021	SELL	$28.63 - $35.64 $291,081 - $362,351	-10,167 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $289,251 - $386,346	10,167 New	10,167 $308,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.